摘要
方剂配伍理论是方剂学研究的核心。对于方剂配伍理论的研究,除传统的君臣佐使组方、性味配伍、升降浮沉配伍、七情和合配伍外,现代学者还提出了框架配伍、组分配伍、功效配伍、剂型更换配伍等。但是,现有研究亟须界定方剂配伍理论中原则、形式、方法、规律等各种概念的内涵、外延,进一步厘清它们之间的相互关系,构建理论框架;单一配伍理论较为片面、单薄,无法体现方剂配伍特点及组方思路,需综合运用多种配伍理论。此外,多数研究仅针对单味药的组分配伍,需进一步加强对多于三味药物之间组分配伍分析,明晰药材组分,以更好地应用组分配伍理论。
The prescription compatibility theory is the essence of the prescriptions study.In addition to the traditional principals of assistant prescriptions,compatibility of character and flavor,compatibility of ascending and descending,floating and sinking as well as compatibility of seven emotions balance,modern scholars have also proposed framework compatibility,compositional compatibility,and efficacy compatibility,dosage form replacement compatibility.However,in these existing researches,it is urgently needed to define the connotation and extension of the various concepts such as principles,forms,methods and laws in prescription compatibility theory,so as to further clarify their interrelationships and construct a theoretical framework.Single compatibility theory is relatively one-sided,which is too simple to reflect the characteristics of prescription compatibility and formulating ideas.Therefore,it is necessary to comprehensively use multiple compatibility theories.In addition,most studies only focus on the compositional compatibility of two kinds of drugs.It is an urge to further strengthen the compositional composition analysis of more than three-flavored drugs to clarify the composition of the medicinal materials,thus to better apply the compositional compatibility theory.
作者
龙天键
许二平
LONG Tianjian;XU Erping(Henan University of Chinese Medicine,Zhengzhou Henan China 450046)
出处
《中医学报》
CAS
2021年第8期1663-1667,共5页
Acta Chinese Medicine
基金
国家自然科学基金项目(81973739)。
关键词
方剂
配伍
君臣佐使
性味配伍
升降浮沉配伍
七情和合配伍
框架理论配伍
组分配伍
功效配伍
剂型更换配伍
prescription
compatibility
principal and assistant prescriptions
character and flavor compatibility
compatibility of ascending and descending,floating and sinking
compatibility of seven emotions balance
framework compatibility
compositional compatibility
efficacy compatibility
dosage form replacement compatibility
